KMCH Approves Slump Sale of Allied Health Sciences Division for ₹84.54 Lakhs

3 min read     Updated on 11 May 2026, 10:42 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Kovai Medical Center and Hospital's Board approved the slump sale of its Allied Health Sciences division to Dr NGP Research and Educational Trust for Rs. 84.54 Lakhs on 11th May, 2026. The AHS division, part of the Education Services segment, contributed Rs. 396.37 lakhs in turnover and Rs. -339.13 lakhs in net worth for FY 31.03.2025. The transaction is a related party deal conducted at arm's length, driven by enhanced regulatory requirements under the National Commission for Allied and Healthcare Professions Act, 2021, with completion expected by 30th November, 2026.

powered bylight_fuzz_icon
40064967

*this image is generated using AI for illustrative purposes only.

Kovai Medical Center and Hospital Limited's Board of Directors, at their meeting held on 11th May, 2026, approved the transfer of its Allied Health Sciences (AHS) Courses division on a slump sale basis to Dr NGP Research and Educational Trust, a public charitable trust engaged in running educational institutions including medical and allied health science courses. The board meeting commenced at 05:00 PM and concluded at 05:45 PM. The proposed transaction is subject to requisite consents, permissions, and approvals as may be required under applicable laws.

Transaction Overview

The slump sale involves the transfer of the company's permission for conducting AHS courses, along with identified assets, liabilities, students, employees, contracts, and related operational elements, on a going concern basis and on an as-is-where-is basis. The transaction is classified as a related party transaction and is being conducted on an arm's length basis, supported by an independent valuation report. The proposed sale is outside any Scheme of Arrangement and does not attract the threshold limits prescribed under Section 180(1)(a) of the Companies Act, 2013 read with Regulation 37A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key transaction details are summarised below:

Parameter: Details
Transaction Type: Slump Sale (Going Concern Basis)
Buyer: Dr NGP Research and Educational Trust
Cash Consideration: Rs. 84.54 Lakhs
BTA Execution Date: On or before 31.05.2026
Expected Completion: By 30th November, 2026
Related Party Transaction: Yes, at arm's length
Shareholding Pattern Change: None

AHS Division Financial Contribution

The AHS Courses division forms part of Kovai Medical Center and Hospital's Education Services segment. The company operates in two segments — Healthcare Services and Education Services. The financial contribution of the AHS division for the financial year ended 31.03.2025 (last audited) is presented below:

Metric: AHS Division % of Company Total
Turnover: Rs. 396.37 lakhs 0.29%
Net Worth: Rs. -339.13 lakhs -0.31%

For context, the company's total net worth for FY 31.03.2025 (last audited) stood at Rs. 1,08,532.05 lakhs, and total turnover for the same period was Rs. 1,37,111.30 lakhs.

Buyer Profile and Promoter Interest

Dr NGP Research and Educational Trust is a public charitable trust established in the year 1990, presently running educational institutions in the fields of Health Sciences, Arts & Science, Engineering & Technology, Teacher Education, and a CBSE-affiliated school. The Trust's net worth for FY 31.03.2025 (last audited) is Rs. 29,031.57 lakhs, and its total income for the same period is Rs. 18,408.24 lakhs.

The following Promoter/Promoter Group directors of Kovai Medical Center and Hospital are interested as trustees of Dr NGP Research and Educational Trust:

  • Dr. Nalla G Palaniswami (DIN: 00013536) — Managing Director
  • Dr. Thavamani Devi Palaniswami (DIN: 00012135) — Joint Managing Director
  • Dr. Arun N Palaniswami (DIN: 02706099) — Executive Director
  • Dr. Purani P Palaniswami (DIN: 02707233) — Director
  • Dr. Mohan S Gounder (DIN: 02479218) — Director

Rationale for the Divestiture

The proposed transaction is driven by enhanced regulatory requirements introduced under the National Commission for Allied and Healthcare Professions Act, 2021, which mandates additional investment in infrastructure and resources for conducting AHS courses. In line with its strategic focus on core medical education programmes and medical care activities with higher resource efficiency and returns, Kovai Medical Center and Hospital has decided to transfer the AHS Courses division to Dr NGP Research and Educational Trust. The Trust, being an established public charitable institution with experience in running educational institutions including medical and health sciences education, is considered well-positioned to continue such courses. The company has stated that the proposed transaction is in the best interests of the company and the students pursuing AHS courses, and there will be no change in the shareholding pattern of the company as a result of this transaction.

Historical Stock Returns for Kovai Medical Center Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-0.52%+0.04%+3.14%+3.14%+3.14%+255.40%

How will Kovai Medical Center redeploy the capital and resources freed up from the AHS division divestiture to strengthen its core Healthcare Services segment?

Could the regulatory pressures from the National Commission for Allied and Healthcare Professions Act, 2021 prompt Kovai Medical Center to divest other non-core education assets in the near future?

Given that the AHS division carried a negative net worth of Rs. 339.13 lakhs, how might this transaction positively impact the company's overall profitability and return on equity metrics going forward?

Kovai Medical Center Hospital
View Company Insights
View All News
like15
dislike

Kovai Medical Center and Hospital Limited Schedules Board Meeting for May 22, 2026 to Review FY26 Financial Results

1 min read     Updated on 25 Apr 2026, 04:02 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Kovai Medical Center and Hospital Limited has scheduled a board meeting for May 22, 2026, to review audited financial results for the quarter and year ended March 31, 2026. The company notified BSE Limited on April 25, 2026, in compliance with SEBI regulations. Trading window restrictions remain in effect until 48 hours after the financial results declaration, as per the company's insider trading code.

powered bylight_fuzz_icon
38658737

*this image is generated using AI for illustrative purposes only.

Kovai Medical Center and Hospital Limited has formally notified BSE Limited about its upcoming board meeting scheduled for May 22, 2026. The meeting will focus on considering the audited financial results for the quarter and year ended March 31, 2026, marking a significant milestone in the company's FY26 reporting cycle.

Board Meeting Details

The healthcare provider submitted its intimation letter dated April 25, 2026, to BSE Limited's Corporate Relationship Department in compliance with regulatory requirements. The communication was signed by R. Ponmanikandan, Company Secretary, and carries the reference number KMCH/SEC/SE/2026-27/2646.

Meeting Parameter: Details
Meeting Date: May 22, 2026
Purpose: Consider Audited Financial Results
Period Covered: Quarter/Year ended March 31, 2026
Security Code: 523323
Security Name: KOVAI

Regulatory Compliance

The board meeting intimation has been issued pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. This regulation mandates listed companies to inform stock exchanges about board meetings where financial results will be considered, ensuring transparency and proper market disclosure.

Trading Window Restrictions

In accordance with the company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, specific trading restrictions are in place. The trading window for dealing in the company's securities will remain closed until 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2026. This closure was initially communicated through the company's letter dated March 19, 2026.

Company Background

Kovai Medical Center and Hospital Limited operates as a NABH accredited healthcare institution, emphasizing excellence in healthcare services. The company is headquartered at 99, Avanashi Road, Coimbatore, and maintains its corporate identity under CIN No: L85110TZ1985PLC001659. The organization recently celebrated its 35th anniversary, marking the period from 1990-2025, highlighting its established presence in the healthcare sector.

Historical Stock Returns for Kovai Medical Center Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-0.52%+0.04%+3.14%+3.14%+3.14%+255.40%

How might Kovai Medical Center's FY26 financial performance impact its expansion plans and capital allocation strategy for the upcoming fiscal year?

Will the company announce any new healthcare infrastructure investments or technology upgrades following the results declaration?

Could strong FY26 results position Kovai Medical Center for potential acquisitions or partnerships in the competitive healthcare sector?

Kovai Medical Center Hospital
View Company Insights
View All News
like19
dislike

More News on Kovai Medical Center Hospital

1 Year Returns:+3.14%